Nautilus Biotechnology, Inc.
NAUT- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001808805
No open-market purchases or sales by Nautilus Biotechnology, Inc. insiders were filed in the last 90 days; 93 institutions reported holding it in 13F filings for Q2 2026, worth $93.7M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Nautilus Biotechnology, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 73 | 77 | +4 |
| Shares | 63.2M | 64.0M | +759.2K (+1.2%) |
| Value | $185.9M | $149.8M | −$36.2M (−19.5%) |
New holders (8)
Institutions that held Nautilus Biotechnology, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Botty Investors LLC | 614,271 | $1.44M | 0.54% |
| CI Private Wealth, LLC | 45,350 | $106.1K | 0.00% |
| Badgley Phelps Wealth Managers, LLC | 30,000 | $70.2K | 0.00% |
| Corebridge Financial, Inc. | 26,211 | $61.3K | 0.00% |
| Mirae Asset Global ETFs Holdings Ltd. | 26,032 | $60.9K | 0.00% |
| Y-Intercept (Hong Kong) Ltd | 23,916 | $56.0K | 0.00% |
| Palumbo Wealth Management LLC | 17,793 | $41.6K | 0.02% |
| Mirae Asset Global Investments Co., Ltd. | 3,740 | $8.53K | 0.00% |
Sold out (4)
Institutions that held Nautilus Biotechnology, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| American International Group, Inc. | 24,880 | $73.1K |
| Millennium Management LLC | 20,637 | $60.7K |
| SG Americas Securities, LLC | 20,209 | $59.0K |
| XTX Topco Ltd | 11,594 | $34.1K |